For the second quarter of the fiscal year ending February 2027, consolidated net sales were 540,713 hundred million yen, an 8.1% increase year-over-year. Operating income was 24,747 hundred million yen, ordinary income was 23,911 hundred million yen, and net income attributable to owners of parent for the interim period was 12,989 hundred million yen. The company operates a single segment comprising drugstore and dispensing pharmacy operations, and store count expanded to 2,360. A revision to the full-year outlook has been announced.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7649","jir_company_name":"Sugi Holdings Co.,Ltd.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-08","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/7649-20261008-02.pdf","jir_short_summary":"For the second quarter of the fiscal year ending February 2027, consolidated net sales were 540,713 hundred million yen, an 8.1% increase year-over-year. Operating income was 24,747 hundred million yen, ordinary income was 23,911 hundred million yen, and net income attributable to owners of parent for the interim period was 12,989 hundred million yen. The company operates a single segment comprising drugstore and dispensing pharmacy operations, and store count expanded to 2,360. A revision to the full-year outlook has been announced.","jir_summary":"### Overview of Performance\nSugi Holdings Co.,Ltd. operates in a single segment consisting of drugstore and dispensing pharmacy businesses. For the second quarter, net sales were 540,713 hundred million yen, representing an 8.1% increase year-over-year. Operating income increased by 247 hundred million yen, while ordinary income declined slightly in the absence of extraordinary factors, and net income decreased substantially. The company expanded its store network through openings and refurbishments, while efforts to strengthen collaboration in the dispensing pharmacy area and rising costs had an impact. The financial summary includes explanations of per-share metrics adjusted for the stock split.\n\n### Future Outlook and Capital Measures\nThe company has revised its full-year outlook for the fiscal year ending February 2027 and specifies assumptions for earnings per share after the stock split. As a capital measure, a third-party allotment that increased capital stock and capital surplus has already been executed, drawing attention to future capital market responses and maintenance of financial soundness. The focus going forward is expected to remain on store expansion strategy, further enhancement of dispensing services, and strengthening competitiveness through ESG initiatives.","jir_financial_highlights":"Net Sales: 540,713 (8.1% increase Year-over-Year (YoY))\nOperating Income: 24,747 (4.4% increase Year-over-Year (YoY))\nOrdinary Income: 23,911 (1.3% decrease Year-over-Year (YoY))\nNet Income Attributable to Owners of Parent (Interim): 12,989 (54.6% decrease Year-over-Year (YoY))\nNumber of Stores: 2,360 (60 new stores, 21 closures, 92 refurbishments)","jir_category":"","jir_hashtags":"#SugiHoldings, #Earnings, #Drugstore, #DispensingPharmacy","jir_key_figures":"Net Sales: 540,713 hundred million yen (8.1% increase YoY)\nOperating Income: 24,747 hundred million yen (4.4% increase YoY)\nNet Income Attributable to Owners of Parent (Interim): 12,989 hundred million yen (54.6% decrease YoY)","jir_meta_title":"Sugi Holdings Co.,Ltd. FY2027 Second Quarter Financial Summary | Net Sales 540,713 hundred million yen (8.1% YoY increase)","jir_meta_description":"Summary of Sugi Holdings Co.,Ltd.'s second quarter results for the fiscal year ending February 2027. Analysis of net sales, operating income, ordinary income, net income and store count trends, with disclosure of a revised full-year outlook.","jir_og_title":"Sugi Holdings Co.,Ltd. Overview of FY2027 Second Quarter Results","jir_og_description":"Sugi Holdings Co.,Ltd.'s second quarter results: net sales 540,713 hundred million yen, operating income 24,747 hundred million yen. Summary of the revised full-year outlook and key investment considerations.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7718,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-128527","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n